PD-L1 expression in our cohort showed no correlation with E-cadherin and vimentin scores but, EMT was reported to be related to PD-L1 overexpression in lung adenocarcinoma, especially in the EGFR-mutant subgroup [15]. The gene discussed is EGFR; the disease is lung adenocarcinoma.